GLP1R and type 2 diabetes mellitus: Finally, iMSD analysis highlighted quantitatively a protective effect against Palmitate induced by cotreatment with Exendin-4 (an agonist of the Glucagon-like peptide-1 receptor, GLP-1R, being used for the treatment of T2D).